Citations

Showing 10 of 108094 citations.

The pulmonary vein meets the left atrium: The where and why of pulmonary vein isolation
Asirvatham, Samuel J. , Prystowsky, Eric N. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | December 27, 2017 | Volume: 29 | Issue: 2 | Pages: 353-355

10.1111/jce.13407 | PMID 29281756 Get It

Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations
Caneus, Julbert, Granic, Antoneta , Rademakers, Rosa , Coughlan, Christina , Chial, Heidi J. , Potter, Huntington , Dickson, Dennis W.

Mayo Clinic

Molecular Biology of the Cell | December 27, 2017 | Volume: 29 | Issue: 5 | Pages: 575-586

10.1091/mbc.e17-01-0031 | PMID 29282277 Get It

Mutant Tau (MAPT) can lead to frontotemporal lobar degeneration (FTLD). Previous studies associated MAPT mutations and altered function with aneuploidy and chromosome instability in human lymphocytes and in Drosophila development. Here we examine whether FTLD-causing mutations in human MAPT induce aneuploidy and apoptosis in the mammalian brain. First, aneuploidy was found in brain cells from MAPT mutant transgenic mice expressing FTLD mutant human MAPT. Then brain neurons from mice homozygous or heterozygous for the Tau (Mapt) null allele were found to exhibit increasing levels of aneuploidy with decreasing Tau gene dosage. To determine whether aneuploidy leads to neurodegeneration in FTLD, we measured aneuploidy and apoptosis in brain cells from patients with MAPT mutations and identified both increased aneuploidy and apoptosis in the same brain neurons and glia. To determine whether there is a direct relationship between MAPT-induced aneuploidy and apoptosis, we expressed FTLD-causing mutant forms of MAPT in karyotypically normal human cells and found that they cause aneuploidy and mitotic spindle defects that then result in apoptosis. Collectively, our findings reveal a neurodegenerative pathway in FTLD-MAPT in which neurons and glia exhibit mitotic spindle abnormalities, chromosome mis-segregation, and aneuploidy, which then lead to apoptosis.
Association between celiac disease and schizophrenia: a meta-analysis
Wijarnpreecha, Karn , Jaruvongvanich, Veeravich , Cheungpasitporn, Wisit , Ungprasert, Patompong , Cheungpasitporn, Wisit , Wijarnpreecha, Karn

Mayo Clinic

European Journal of Gastroenterology & Hepatology | December 27, 2017 | Volume: 30 | Issue: 4 | Pages: 442-446

10.1097/meg.0000000000001048 | PMID 29280918 Get It

Background/objective Recent epidemiologic studies have suggested that patients with celiac disease might be at an increased risk of schizophrenia. However, the data on this risk remain inconclusive. This meta-analysis was conducted with the aim to summarize all available evidence. Methods A literature search was carried out using MEDLINE and Embase database from inception to June 2017. Studies that compared the risk of schizophrenia among patients with celiac disease versus individuals without celiac disease were included. Pooled odds ratio and 95% confidence interval were calculated using a random-effect, generic inverse-variance method. Results Of the 284 retrieved studies, four met our eligibility criteria and were included in the analysis. We found a higher risk of schizophrenia among patients with celiac disease compared with individuals without celiac disease with the pooled odds ratio of 2.03 (95% confidence interval: 1.45–2.86). The statistical heterogeneity of this study was insignificant (I 2=0%). Conclusion This systematic review and meta-analysis found a significantly higher risk of schizophrenia among patients with celiac disease.
Perforated balloon technique: A simple and handy technique to combat no‐reflow phenomenon in coronary system
Patel, Tejas , Shah, Sanjay , Gulati, Rajiv , Kwan, Tak , Cohen, Mauricio G. , Pancholy, Samir , Cohen, Mauricio G , Pancholy, Samir B

Mayo Clinic

Catheterization and Cardiovascular Interventions | December 27, 2017 | Volume: 92 | Issue: 5 | Pages: 890-894

10.1002/ccd.27477 | PMID 29280545 Get It

AbstractObjectiveExamining the efficacy and outcomes of intracoronary (IC) instillation of adenosine using a novel perforated balloon technique (PBT) to combat no‐reflow phenomenon during percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS).BackgroundOccurrence of no‐reflow during PCI is a serious adverse prognostic event and inability to re‐establish better flow is associated with poor outcomes. Several pharmacological and non‐pharmacological interventions have been used to treat this situation. This series describes the use of PBT for IC adenosine administration and its effects on outcomes during real world interventional practice.MethodsSubjects comprised of 24 patients with ACS (out of a total of 1,634 patients undergoing PCI between January 2016 and June 2017) in whom we used PBT for IC administration of adenosine to treat coronary no‐reflow.ResultsPBT for IC adenosine instillation was used in 24 (1.5%) of 1,634 patients undergoing PCI. TIMI grade III flow was established in 21 patients (87.5%). In two patients (8.3%) TIMI grade II flow was established and in one patient (4.2%) we were unsuccessful.ConclusionWe demonstrate the safety and efficacy of a novel strategy for adenosine instillation in the distal coronary bed, the PBT. This technique enables rapid and cost‐effective treatment of no‐reflow phenomenon during PCI for ACS.
Sex hormones in alcohol consumption: a systematic review of evidence
Erol, Almıla , Ho, Ada Man‐Choi , Winham, Stacey J. , Karpyak, Victor M. , Ho, Ada M-C , Winham, Stacey J , Karpyak, Victor

Mayo Clinic

Addiction Biology | December 27, 2017 | Volume: 24 | Issue: 2 | Pages: 157-169

10.1111/adb.12589 | PMID 29280252 Get It

AbstractSex hormones play an important role in establishing sex‐distinctive brain structural and functional variations that could contribute to the sex differences in alcohol consumption behavior. Here, we systematically reviewed articles that studied sex hormone impacts on alcohol consumption and alcohol use disorder (AUD). An extensive literature search conducted in MEDLINE, PubMed, Scopus and CINAHL databases identified 776 articles, which were then evaluated for pre‐specified criteria for relevance and quality assurance. A total of 50 articles, including 19 human studies and 31 animal studies, were selected for this review. Existing evidence supports the association of increased testosterone level and increased risk for alcohol use and AUD in males but results are inconclusive in females. In contrast, the evidence supports the association of increased estrogen level and increased alcohol use in females, with mixed findings reported in males. Much less is known about the impact of progestins on alcohol use and misuse in human subjects. Future observational and experimental studies conducted in both sexes with a comprehensive hormone panel are needed to elucidate the impact of the interplay between various sex hormone levels during various developmental stages on alcohol use‐related phenotypes and AUD.
Cross‐linkable graphene oxide embedded nanocomposite hydrogel with enhanced mechanics and cytocompatibility for tissue engineering
Liu, Xifeng , Miller, A. Lee , Waletzki, Brian E., Lu, Lichun , Miller, Alan Lee

Mayo Clinic

Journal of Biomedical Materials Research Part A | December 27, 2017 | Volume: 106 | Issue: 5 | Pages: 1247-1257

10.1002/jbm.a.36322 | PMID 29280326 Get It

AbstractGraphene oxide (GO) is an attractive material that can be utilized to enhance the modulus and conductivities of substrates and hydrogels. To covalently cross‐link graphene oxide sheets into hydrogels, abundant cross‐linkable double bonds were introduced to synthesize the graphene‐oxide‐tris‐acrylate sheet (GO‐TrisA). Polyacrylamide (PAM) nanocomposite hydrogels were then fabricated with inherent covalently and permanently cross‐linked GO‐TrisA sheets. Results showed that the covalently cross‐linked GO‐TrisA/PAM nanocomposite hydrogel had enhanced mechanical strength, thermo stability compared with GO/PAM hydrogel maintained mainly by hydrogen bonding between PAM chains and GO sheets. In vitro cell study showed that the covalently cross‐linked rGO‐TrisA/PAM nanocomposite hydrogel had excellent cytocompatibility after in situ reduction. These results suggest that rGO‐TrisA/PAM nanocomposite hydrogel holds great potential for tissue engineering applications. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1247–1257, 2018.
Osteogenic Stimulation of Human Adipose-Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2
Samsonraj, Rebekah M. , Dudakovic, Amel , Manzar, Bushra , Sen, Buer , Dietz, Allan B. , Cool, Simon M. , Rubin, Janet , Wijnen, André J. van , van Wijnen, Andre J , Dietz, Allan B

Mayo Clinic

Stem Cells Translational Medicine | December 27, 2017 | Volume: 7 | Issue: 2 | Pages: 197-209

10.1002/sctm.17-0086 | PMID 29280310 Get It

Abstract Strategies for musculoskeletal tissue regeneration apply adult mesenchymal stem/stromal cells (MSCs) that can be sourced from bone marrow- and lipo-aspirates. Adipose tissue-derived MSCs are more easily harvested in the large quantities required for skeletal tissue-engineering approaches, but are generally considered to be less osteogenic than bone marrow MSCs. Therefore, we tested a new molecular strategy to improve their osteogenic lineage-differentiation potential using the fungal metabolite cytochalasin D (CytoD). We show that CytoD, which may function by redistributing the intracellular location of β-actin (ACTB), is a potent osteogenic stimulant as reflected by significant increases in alkaline phosphatase activity, extracellular matrix mineralization, and osteoblast-related gene expression (e.g., RUNX2, ALPL, SPARC, and TGFB3). RNA sequencing analyses of MSCs revealed that acute CytoD treatment (24 hours) stimulates a broad program of osteogenic biomarkers and epigenetic regulators. CytoD decreases mRNA and protein levels of the Polycomb chromatin regulator Enhancer of Zeste Homolog 2 (EZH2), which controls heterochromatin formation by mediating trimethylation of histone 3 lysine 27 (H3K27me3). Reduced EZH2 expression decreases cellular H3K27me3 marks indicating a global reduction in heterochromatin. We conclude that CytoD is an effective osteogenic stimulant that mechanistically functions by blocking both cytoplasmic actin polymerization and gene-suppressive epigenetic mechanisms required for the acquisition of the osteogenic phenotype in adipose tissue-derived MSCs. This finding supports the use of CytoD in advancing the osteogenic potential of MSCs in skeletal regenerative strategies.
Organ Donor Management: Part 1. Toward a Consensus to Guide Anesthesia Services During Donation After Brain Death
Souter, Michael J. , Eidbo, Elling E., Findlay, James Y. , Lebovitz, Daniel J. , Moguilevitch, Marina , Neidlinger, Nikole , Wagener, Gerhard, Paramesh, Anil , Niemann, Claus U. , Roberts, Pamela R. , Pretto, Ernesto A.

Mayo Clinic

Seminars in Cardiothoracic and Vascular Anesthesia | December 26, 2017 | Volume: 22 | Issue: 2 | Pages: 211-222

10.1177/1089253217749053 | PMID 29276852 Get It

Worldwide 715 482 patients have received a lifesaving organ transplant since 1988. During this time, there have been advances in donor management and in the perioperative care of the organ transplant recipient, resulting in marked improvements in long-term survival. Although the number of organs recovered has increased year after year, a greater demand has produced a critical organ shortage. The majority of organs are from deceased donors; however, some are not suitable for transplantation. Some of this loss is due to management of the donor. Improved donor care may increase the number of available organs and help close the existing gap in supply and demand. In order to address this concern, The Organ Donation and Transplantation Alliance, the Association of Organ Procurement Organizations, and the Transplant and Critical Care Committees of the American Society of Anesthesiologists have formulated evidence-based guidelines, which include a call for greater involvement and oversight by anesthesiologists and critical care specialists, as well as uniform reporting of data during organ procurement and recovery.
Inferring modes of evolution from colorectal cancer with residual polyp of origin
Kim, Minsoo , Druliner, Brooke R., Vasmatzis, Nikolaos , Bae, Taejeong , Abyzov, Alexej , Boardman, Lisa A., Chia, Nicholas , Abyzov, Alexej , Bae, Taejeong , Druliner, Brooke R. , Chia, Nicholas , Boardman, Lisa A.

Mayo Clinic

Oncotarget | December 26, 2017 | Volume: 9 | Issue: 6 | Pages: 6780-6792

10.18632/oncotarget.23687 | PMID 29467928 Get It

Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases
Choi, Won‐Tak , Brown, Ian , Ushiku, Tetsuo , Yozu, Masato , Setia, Namrata , Srivastava, Amitabh , Johncilla, Melanie , Pai, Rish K. , Fukayama, Masashi , Misdraji, Joseph , Lauwers, Gregory Y. , Brown, Ian S , Gill, Ryan M. , Srivastava, Amitabh

Mayo Clinic

Histopathology | December 26, 2017 | Volume: 72 | Issue: 6 | Pages: 1007-1014

10.1111/his.13460 | PMID 29278427 Get It

AimsThere is limited information regarding the clinicopathological and immunohistochemical characteristics of gastric pyloric gland adenomas (PGAs).Methods and resultsSixty‐seven cases of gastric PGA from 57 patients were analysed. PGAs occurred with similar frequency in men and women (47.4 and 52.6%, respectively), with a mean age of 66 years. Most presented in the gastric body/fundus (67.2%). Fifteen cases (22.4%) developed against a background of autoimmune gastritis (AIG), whereas normal mucosa was seen in 35.8%. Only 16.4% (11 cases) developed in patients with a genetic predisposition, most commonly familial adenomatous polyposis. Low‐grade lesions had a mean size of 1.5 cm, while PGAs with high‐grade dysplasia (HGD) or adenocarcinoma had a mean size of 3.5 cm (P < 0.001) and more commonly showed tubulovillous architecture (50.0 versus 25.6% in low‐grade dysplasia; P = 0.040). Most PGAs (61.2%) co‐expressed mucin (MUC)5AC and MUC6 (mixed type), which was associated significantly with HGD or adenocarcinoma (P = 0.013). AIG was also associated with HGD (P = 0.027), but genetic predisposition did not correlate with the grade of dysplasia (P = 0.793). The recurrence rate of PGA was similar for high‐ (11.8%) and low‐grade lesions (7.4%) (P = 0.624).ConclusionsThe risk of HGD increases with the size of PGA, tubulovillous architecture and the presence of AIG as well as mixed immunophenotype. As the overall local recurrence rate is less than 10%, PGAs may be treated conservatively, but they should be excised completely if possible, particularly if they are large or show high‐grade features.